AnxietyAnxiété-IDENCT07418255
Level of Anxiety Among Nurses Working in Psychiatric Settings
An observational study of Anxiety, run by Université de Reims Champagne-Ardenne at 2 sites in France.
Trial summary
Anxiety is common among healthcare professionals, particularly nurses, who are faced with major responsibilities and stressful situations. In psychiatric settings, this stress is exacerbated by exposure to patients with serious mental disorders (schizophrenia, bipolarity, personality disorders), who are often… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Anxiety
- What is being tested?
- data collection
- How many people
- 543 participants
- Where
- 2 sitesFrance
- Study dates
- 25 Feb 2025to 15 Jun 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: State-registered nurse
Who may be able to join
- State-registered nurse,
- Practising for more than one year in a psychiatric environment, whether in a full or partial hospitalisation unit, or in a medical-psychological centre
- Whatever positions they previously held
- Agreeing to take part in the study.
Who cannot join
- nursing students
- Practising for less than a year in a psychiatric setting
- Protected by law (guardianship, curatorship, safeguard of justice)
- Refusing to take part in the study
Trial locations and contacts
2 sites in 1 country.
France2 sites
Gestonnairedu CURRS
Reims, Champagne-Ardenne, 51100
Ufr Medecine Urca
Reims, 51100
About this study
Anxiety is common among healthcare professionals, particularly nurses, who are faced with major responsibilities and stressful situations. In psychiatric settings, this stress is exacerbated by exposure to patients with serious mental disorders (schizophrenia, bipolarity, personality disorders), who are often unpredictable and sometimes violent. Nurses in this sector face an increased risk of violence, work overload and an emotionally taxing environment, which can lead to chronic anxiety, burn-out and even mental health problems.
These professionals also have to manage the ambiguity of their role, between caring for and containing patients, in a context where training in crisis management is often inadequate.
Read the detailed description
The primary objective is to describe the level of anxiety in nurses practising in psychiatric settings.
The secondary objectives are :
- describe the impact of anxiety levels on professional and personal life.
- to identify the factors associated with anxiety levels in nurses working in psychiatry.
- Conditions
- Anxiety
- Being tested
- data collection
- Keywords
- Anxiety, healthcare professionals, nurse, psychiatry
- Medical subject headings
- Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
data collectionOther
data collection
What is being measured
The primary outcome is the main question the study is designed to answer.
STAI Scale (State Trait Anxiety Inventory, Y-A form)
the level of anxiety assessed by Spielberger's State Anxiety Inventory (STAI - Trait Anxiety Inventory Form Y-A scale). (12)
Measured: Day 0
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Feb 2026
- Study start25 Feb 2025
- Primary completion13 May 2025
- Study completion15 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AnxietyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 543 participants (actual)
Sponsor and investigators
- Lead sponsor
- Université de Reims Champagne-Ardenne
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07418255
- Sponsor's protocol ID
- 2024_RIPH_25_anxiete-IDE
- Acronym
- Anxiété-IDE
- Status last verified
- Feb 2026
- First submitted
- 10 Feb 2026
- Last updated
- 18 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 18 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Level of Anxiety Among Nurses Working in Psychiatric Settings
- ClinicalTrials.gov ID
- NCT07418255
- Acronym / sponsor ID
- Anxiété-IDE / 2024_RIPH_25_anxiete-IDE
- Conditions
- Anxiety
- Keywords
- Anxiety, healthcare professionals, nurse, psychiatry
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 543 participants (actual)
- Lead sponsor
- Université de Reims Champagne-ArdenneUniversity, hospital or other
- Study start
- 25 Feb 2025 (actual)
- Primary completion
- 13 May 2025 (actual)
- Study completion
- 15 Jun 2025 (actual)
- First posted
- 18 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Anxiety is common among healthcare professionals, particularly nurses, who are faced with major responsibilities and stressful situations. In psychiatric settings, this stress is exacerbated by exposure to patients with serious mental disorders (schizophrenia, bipolarity, personality disorders), who are often unpredictable and sometimes violent. Nurses in this sector face an increased risk of violence, work overload and an emotionally taxing environment, which can lead to chronic anxiety, burn-out and even mental health problems.
These professionals also have to manage the ambiguity of their role, between caring for and containing patients, in a context where training in crisis management is often inadequate.
Detailed description
The primary objective is to describe the level of anxiety in nurses practising in psychiatric settings.
The secondary objectives are :
- describe the impact of anxiety levels on professional and personal life.
- to identify the factors associated with anxiety levels in nurses working in psychiatry.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- State-registered nurse
Key inclusion criteria (4 listed)
- State-registered nurse,
- Practising for more than one year in a psychiatric environment, whether in a full or partial hospitalisation unit, or in a medical-psychological centre
- Whatever positions they previously held
- Agreeing to take part in the study.
Key exclusion criteria (4 listed)
- nursing students
- Practising for less than a year in a psychiatric setting
- Protected by law (guardianship, curatorship, safeguard of justice)
- Refusing to take part in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| data collectiondata collection | Other | – |
Primary outcome
STAI Scale (State Trait Anxiety Inventory, Y-A form)
Time frame: Day 0
the level of anxiety assessed by Spielberger's State Anxiety Inventory (STAI - Trait Anxiety Inventory Form Y-A scale). (12)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Feb 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Anxiety
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Recruiting
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
Mental Health and General Well-being
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Anxiety, run by Université de Reims Champagne-Ardenne at 2 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
STAI Scale (State Trait Anxiety Inventory, Y-A form) (time frame: Day 0). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2026.